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Removal of the assembly factor eukaryotic initiation factor 6 (eIF6) is critical for late cytoplasmic maturation
of 60S ribosomal subunits. In mammalian cells, the current model posits that eIF6 release is triggered following
phosphorylation of Ser 235 by activated protein kinase C. In contrast, genetic studies in yeast indicate
a requirement for the ortholog of the SBDS (Shwachman-Bodian-Diamond syndrome) gene that is mutated
in the inherited leukemia predisposition disorder Shwachman-Diamond syndrome (SDS). Here, by isolating late
cytoplasmic 60S ribosomal subunits from Sbds-deleted mice, we show that SBDS and the GTPase elongation
factor-like 1 (EFL1) directly catalyze eIF6 removal in mammalian cells by a mechanism that requires GTP
binding and hydrolysis by EFL1 but not phosphorylation of eIF6 Ser 235. Functional analysis of disease-
associated missense variants reveals that the essential role of SBDS is to tightly couple GTP hydrolysis by
EFL1 on the ribosome to eIF6 release. Furthermore, complementary NMR spectroscopic studies suggest
unanticipated mechanistic parallels between this late step in 60S maturation and aspects of bacterial ribosome
disassembly. Our findings establish a direct role for SBDS and EFL1 in catalyzing the translational activation
of ribosomes in all eukaryotes, and define SDS as a ribosomopathy caused by uncoupling GTP hydrolysis from
eIF6 release.
[Keywords: bone marrow failure syndromes; ribosome assembly; eIF6; human genetics; leukemia; ribosomopathy;
NMR]
Supplemental material is available for this article.
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Shwachman-Diamond syndrome (SDS; OMIM 260400)
is an autosomal recessive disorder characterized by bone
marrow dysfunction with a striking cumulative risk of
progression tomyelodysplastic syndrome (MDS) and acute
myeloid leukemia (AML) (Donadieu et al. 2005) that is
caused by mutations in the essential, highly conserved
SBDS (Shwachman-Bodian-Diamond syndrome) gene
(Boocock et al. 2003), whose specific function remains
unknown. Genetic studies in Saccharomyces cerevisiae
indicate that the SBDS ortholog Sdo1 and the GTPase
elongation factor-like 1 (Efl1), a structural homolog of
elongation factor G (EF-G), function in a pathway to
release and recycle the essential nucleolar factor Tif6
(mammalian eukaryotic initiation factor 6 [eIF6]) from
late cytoplasmic pre-60S ribosomal subunits (Menne
et al. 2007). Tif6 is critical for the biogenesis and nuclear
export of pre-60S subunits (Basu et al. 2001), and acts as
10These authors contributed equally to this work.
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a ribosomal anti-association factor by physically blocking
intersubunit bridge formation (Gartmann et al. 2010).
Therefore, dissociation of Tif6 from nascent 60S ribo-
somes is essential to allow the assembly of actively
translating 80S subunits (Ceci et al. 2003).
Multiple gain-of-function TIF6 alleles suppress the pre-
60S nuclear export defect and cytoplasmic mislocaliza-
tion of Tif6 observed in cells deleted for SDO1 (sdo1D)
(Menne et al. 2007) or EFL1 (efl1D) (Becam et al. 2001;
Senger et al. 2001) by reducing the affinity of Tif6 for the
ribosome, suggesting that the release of Tif6 may be
directly catalyzed by the concerted action of Sdo1 and
Efl1. However, direct biochemical evidence supporting
this notion is lacking. Indeed, Efl1 alone was reported to
dissociate 60S–Tif6 complexes in vitro in the presence
of GTP (Senger et al. 2001). Although cosedimentation
of human SBDS with free cytoplasmic 60S ribosomal
subunits in sucrose gradients (Ganapathi et al. 2007)
would be consistent with a conserved role for SBDS in
60S subunit maturation, the current model in mamma-
lian cells posits that eIF6 removal is triggered following
phosphorylation of Ser 235 by protein kinase C (PKC) and
RACK1 (receptor for activated protein C) (Ceci et al.
2003). Furthermore, diverse alternate functions for SBDS
in mammalian cells have been suggested, including
mitotic spindle stabilization (Austin et al. 2008), chemo-
taxis (Wessels et al. 2006), Fas ligand-induced apoptosis
(Rujkijyanont et al. 2008), cellular stress responses (Ball
et al. 2009), and Rac2-mediated monocyte migration
(Leung et al. 2010). Thus, despite the prior genetic studies
in yeast, the mechanism of eIF6 release in mammalian
cells is controversial, biochemical evidence supporting
direct catalysis of eIF6 release by SBDS and EFL1 in
eukaryotic cells is currently lacking, and the specific
function of the SBDS protein, its mode of action, and the
molecular mechanism of the cooperative interaction
with EFL1 remain obscure.
To resolve these issues, we solved a high-resolution
NMR structure of the human SBDS protein and bio-
chemically reconstituted eIF6 release for the first time
ex vivo using genetically stalled pre-60S subunits isolated
from Sbds-deleted mice. We demonstrate that human
SBDS and EFL1 cooperate to directly catalyze eIF6 re-
moval from mammalian pre-60S subunits by a mecha-
nism that requires GTP binding and hydrolysis by EFL1
but not eIF6 phosphorylation on Ser 235. We reveal that
the essential role of the SBDS protein is to tightly couple
the activation of GTP hydrolysis on the ribosome and
eIF6 release, and identify a conserved residue (Lys151)
mutated in SDS that is required for the cooperative
interaction with EFL1. Furthermore, complementary
NMR studies suggest unanticipatedmechanistic parallels
between this late step in 60S ribosome biogenesis and
aspects of bacterial ribosome disassembly. By elucidating
the conserved mechanism of eIF6 release in eukaryotes,
this study provides compelling evidence that SDS is a
ribosomopathy caused by uncoupling GTP hydrolysis by
EFL1 from eIF6 release on the ribosome. Our data support
the evaluation of strategies that promote eIF6 removal for
SDS therapy.
Results
Histopathological abnormalities in Sbds-deleted liver
To test the hypothesis that SBDS and EFL1 cooperate to
directly trigger the release of eIF6 from pre-60S ribosomal
subunits, we generated a floxed Sbds allele (Sbdsfl) by
gene targeting in mouse embryonic stem cells (Fig. 1A,B;
Supplemental Fig. S1), designing the targeting construct
such that Cre-mediated recombination of the loxP elements
would remove Sbds exon 2. The resulting chimeras were
crossed with wild-type C57Bl/6 mice to produce floxed
heterozygous Sbdsfl/+ animals (Fig. 1C). Sbdsfl/+ mice were
crossed with a germline deleter transgenic strain (Schwenk
et al. 1995) to generate mice that were heterozygous for a
deleted Sbds allele (Sbds-/+). Excision of exon 2 was con-
firmed by PCR of tail DNA (Fig. 1D).
As homozygous exon 2 deletion was embryonic-lethal
(data not shown), Sbdsfl/flTg:Mx1-cremice were bred with
Sbdsfl/-Tg:Mx1-cre mice to conditionally delete the Sbds
gene. Following induction of Cre recombinase by admin-
istration of poly(I:C) for 2 wk, PCR for Sbds transcripts
(data not shown) and immunoblotting for the Sbds pro-
tein indicated Sbds deletion of 100% in the livers of
Sbdsfl/flTg:Mx1-cre and Sbdsfl/-Tg:Mx1-cre mice (Fig. 1E).
No recombination was observed in control mice lacking
the Tg:Mx1-cre transgene or inmice injected with vehicle
alone (data not shown).
Prominent histological abnormalities were observed in
the livers of Sbds-deleted mice (Fig. 1F, panels I–IX). Com-
pared with undeleted controls (Fig. 1F, panel I), Sbds-
deleted livers showed disordered architecture in zone 2
between the portal triads and central veins (Fig. 1F, panel
II), with a range of degenerative hepatocyte appearances,
including hydropic cytoplasmic swelling (Fig. 1F, panel III),
nuclear cavitation, degenerative nuclear change, necrosis,
and apoptosis (Fig. 1F, panels IV,V). Many zone 2 hepato-
cytes showed striking nucleolar abnormalities, including
enlarged, ring-shaped nucleoli with eosinophilic centers
(Fig. 1F, panel VI) and multiple enlarged eosinophilic
nucleoli of varying sizes and shapes (Fig. 1F, panel VII).
There were also scattered subcapsular areas of hepato-
cyte necrosis with an associated acute inflammatory
reaction (Fig. 1F, panels VIII,IX).
Sbds deletion causes a ribosomal subunit-joining
defect
We postulated that the striking histological abnormali-
ties in Sbds-deleted livers might be a consequence of a
primary defect in 60S ribosomal subunit maturation. To
test this hypothesis, we examined the abundance of cyto-
plasmic ribosomal subunits,monosomes, and polysomes in
liver cell extracts by performing sucrose gradient centri-
fugation (Fig. 2A). Compared with undeleted controls,
Sbds-deleted extracts showed accumulation of free cy-
toplasmic 40S and 60S subunits and halfmer ribosomes
(representing 43S initiation complexes that are stalled at
the AUG start codon awaiting binding of 60S subunits),
with no significant difference in the ratio of 60S to 40S
subunits (Supplemental Fig. S2). These data indicate that
Finch et al.
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Sbds deletion causes a ribosomal subunit-joining defect
in mammalian cells in vivo.
Nucleolar eIF6 is not limiting for 60S subunit
biogenesis in Sbds-deleted cells
The absence of a ribosomal subunit imbalance following
Sbds deletion in mouse livers contrasts with the under-
accumulation of 60S ribosomal subunits in sdo1D yeast
cells where 60S subunit deficiency is secondary to the
delayed preribosomal RNA (rRNA) processing and de-
fective nuclear export of pre-60S subunits caused by
impaired nucleolar recycling of Tif6 (Menne et al. 2007).
We hypothesized that nuclear export of pre-60S subunits
might be maintained in Sbds-deleted liver because eIF6
is not limiting in the nucleolus. To test this, liver cells
were fractionated into cytoplasmic, soluble, and insolu-
ble nuclear extracts and immunoblotted to detect eIF6. In
Sbds-deleted liver cells, eIF6 accumulates in the cyto-
plasmic, nuclear, and nucleolar fractions (Fig. 2B). Thus,
in contrast with sdo1D yeast cells where Tif6 is markedly
redistributed from the nucleolus to the cytoplasm, the
Figure 1. Histopathological abnormalities
in Sbds-deleted mouse livers. (A) Schematic
of the targeted Sbds allele on mouse chro-
mosome 5. Exons I–V are shown in red, loxP
sites are shown in yellow, and the neomycin
cassette is shown in green. (B) Representa-
tive filter hybridization analysis of neomy-
cin-resistant embryonic stem cell clones.
Genomic DNA was digested with BamH1
and hybridized to the 59 probe (Supplemental
Fig. S1). The 15-kb- and 11-kb bands repre-
sent wild-type Sbds+ (lanes 1,3) and targeted
Sbdsfl (lane 2) alleles, respectively. (C) Rep-
resentative filter hybridization for genotyp-
ing (Geno) of genomic tail DNA from mice
carrying wild-type (+) and targeted (fl) Sbds
alleles. DNA was digested with BamH1 and
hybridized with the 59 probe. (D) PCR geno-
typing of tail DNA to detect wild-type (+) and
floxed (fl) (panel I) or exon 2 deleted () (panel
II) Sbds alleles. The sizes of the PCR prod-
ucts are indicated. (E) Sbds protein is absent
in Sbds-deleted mouse livers. The Sbds ge-
notype and the absence (Cre) or presence
(+Cre) of the pMx1-cre transgene are indi-
cated. Liver extracts were immunoblotted to
visualize Sbds and Rps14. (F) Histopatholog-
ical abnormalities in Sbds-deleted mouse
livers. (Panels I–IX) H&E sections of livers
from representative Sbdsfl/- mice after 4 wk
of treatment with poly(I:C) in the absence
(Cre) or presence (+Cre) of the pMx1-cre
transgene demonstrating normal zone 2
(503) (panel I); disordered architecture in
zone 2 between the portal triads and central
veins (503) (panel II); hydropic cytoplasmic
swelling of hepatocytes in zone 2 (4003)
(panel III); hepatocytes showing apparent
cavitation of the nucleus (thin arrow), de-
generative nuclear change (thick arrow), and
apoptotic cells (asterisks) (4003) (panel IV);
a swollen hepatocyte containing an enlarged
abnormal nucleus (arrow) (4003) (panel V);
an enlarged, ring-shaped nucleolus with an
eosinophilic center (arrow) (4003) (panel VI);
multiple enlarged eosinophilic nucleoli (ar-
row) (4003) (panel VII); the area of necrosis
adjacent to the liver capsule with surround-
ing neutrophil infiltrate (asterisk) (1003)
(panel VIII); and the necrotic area showing
karyolysis of hepatocytes (4003) (panel IX).
See also Supplemental Figure S1.
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level of eIF6 is not limiting in the nucleolus of Sbds-
deleted cells, thereby maintaining 60S subunit biogenesis
and export.
Accumulation of stalled late cytoplasmic pre-60S
ribosomes in Sbds-deleted cells
We hypothesized that the subunit-joining defect in Sbds-
deleted cells might be a consequence of failure to release
one or more late trans-acting ribosome assembly factors
from the 60S intersubunit interface, and anticipated that
such factors would accumulate in the cytoplasm in the
absence of Sbds. Indeed, compared with undeleted con-
trols, we observed significant cytoplasmic accumulation
of the late pre-60S assembly factors eIF6, Nmd3, and Lsg1
in Sbds-deleted extracts relative to Gapdh (Fig. 2B). Ad-
ditionally, we observed cytoplasmic accumulation of the
GTPase Efl1 (NP_780526) but not the early nucleolar
GTPase Nog1 or the nuclear protein nucleophosmin
(Npm). Furthermore, Ebp1, the mammalian ortholog of
the yeast 60S biogenesis factor Arx1, did not appear to
accumulate or show redistribution upon Sbds deletion.
The Sbds protein itself was clearly cytoplasmic, with no
detectable signal in the nucleolar fraction (marked by
Nog1).
In light of the ribosomal subunit-joining defect in the
absence of Sbds, we hypothesized that the cytoplasmic
accumulation of late pre-60S assembly factors was most
likely due to their retention on late pre-60S particles. We
therefore testedwhether eIF6,Nmd3, andLsg1 cofraction-
ated with cytoplasmic pre-60S ribosomes by sucrose
gradient sedimentation analysis and immunoblotting of
liver cell extracts (Fig. 2C). The absorbance profile of the
sucrose gradients at 254 nm revealed the distribution of
40S and 60S subunits, 80S monosomes, and polysomes,
while antiserum to Rpl28 revealed the 60S subunits (also
highlighted by antiserum to the stalk protein P0 and anti-
Ebp1) and Rps14 antiserum detected the 40S subunits
(data not shown). The assembly factors eIF6, Nmd3, and
Lsg1 cosedimented with cytoplasmic pre-60S ribosomal
subunits and did not accumulate significantly at the top
of the sucrose gradient on sedimentation analysis of Sbds-
deleted liver cell extracts. The Sbds protein cofraction-
ated with pre-60S subunits in undeleted extracts, with
a minor portion in the free fraction at the top of the
gradient, but was undetectable in Sbds-deleted extracts,
as expected. These data indicate that deletion of Sbds
causes a ribosomal subunit-joining defect associated with
the cytoplasmic accumulation of pre-60S particles carry-
ing the ribosome assembly factors eIF6, Nmd3, and Lsg1.
As both Tif6 and Nmd3 bind to the intersubunit
interface of the 60S subunit in yeast (Gartmann et al.
2010; Sengupta et al. 2010), we considered the most likely
cause of the subunit-joining defect in Sbds-deleted cells
to be due to a failure to release eIF6 and Nmd3 from the
intersubunit interface of late pre-60S subunits.
Genome-wide arrays reveal extensive overlap
in the genetic interactions between SDO1 and EFL1
We postulated that eIF6 rather than Nmd3 might be the
direct target of SBDS and EFL1. To provide further support
Figure 2. 60S subunit maturation defect in Sbds-deleted mouse livers. (A) Polysome profiles of liver cell extracts from undeleted
(Cre) or Sbds-deleted (+Cre) mice. Halfmer ribosomes are indicated with arrows. (B) Cytoplasmic accumulation of late pre-60S
assembly factors in Sbds-deleted cells. Subcellular fractions from undeleted (Cre) or Sbds-deleted (+Cre) liver cells were
immunoblotted to visualize the indicated factors. Rps14 and Rpl28 reveal the 40S and 60S ribosomal subunits, respectively. Gapdh
is a cytoplasmic marker, Npm is a nuclear marker, and histone H3 is a chromatin marker. (C) Cytoplasmic fraction; (N) soluble nuclear
fraction; (I) insoluble nuclear fraction containing nucleoli and chromatin. (C) Cosedimentation of eIF6, Nmd3, and Lsg1 with pre-60S
subunits in Sbds-deleted cells. Extracts from undeleted (Cre) or Sbds-deleted (+Cre) liver cells as above were fractionated by sucrose
gradient sedimentation and immunoblotted to visualize the indicated factors. P0 reveals the 60S ribosomal stalk, and the
sedimentation positions of the 40S, 60S, and 80S ribosomal particles are indicated. See also Supplemental Figure S2.
Finch et al.
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for this hypothesis, we turned to S. cerevisiae, as we had
demonstrated previously that the fitness defect of yeast
cells deleted for SDO1 (sdo1D), EFL1 (efl1D), or both
(sdo1D efl1D) is rescued by a plasmid carrying the do-
minant TIF6-V192F suppressor allele (Menne et al. 2007).
Strikingly, 11 spontaneous suppressor yeast strains that
had bypassed the fitness defect of the sdo1D efl1D double-
deletion mutant harbored point mutations in the TIF6
gene (N9Y,N9D, V15I, V15D, R61G,Q75R, L101I, L101V,
A103S, A103T, and A103V).
We next screened for synthetic sick/lethal interactions
in a genome-wide array of two-factor crosses using sdo1D
and efl1D query strains (harboring a dominant gain-of-
function TIF6 suppressor allele) and the set of ;5000
viable deletion alleles. This analysis revealed an over-
lapping set of 36 identical genetic interactions shared
between SDO1 and EFL1 (accounting for ;50% of the
SDO1 genetic interactions identified, P; 0) (Supplemen-
tal Fig. S3; Supplemental Table S1). Taken together, these
genetic data strongly support the hypothesis that Sdo1
and Efl1 function in a common pathway upstream of Tif6,
raising the possibility that Tif6 is the direct target of Sdo1
and Efl1 in yeast, and that, by implication, eIF6 is the
direct target of SBDS and EFL1 in mammalian cells.
Human SBDS and EFL1 are necessary and sufficient
to catalyze eIF6 release
We set out to obtain direct evidence in mammalian cells
that the release of eIF6 from pre-60S ribosomal subunits is
directly catalyzed by the cooperative interaction between
human SBDS and EFL1. We biochemically reconstituted
an ex vivo eIF6 release assay by adding recombinant hu-
man SBDS and EFL1 to eIF6-loaded pre-60S subunits
isolated from Sbds-deleted mouse liver. A schematic
overview of the eIF6 release assay is shown in Figure 3A.
Endogenous murine Sbds and Efl1 were not detected on
the isolated pre-60S subunits by immunoblotting (data
not shown). As shown in Figure 3B, dissociation of eIF6
was triggered by human SBDS and EFL1 and the nucleotide
Figure 3. SBDS and EFL1 cooperate to directly
catalyze eIF6 release. (A) Schematic of eIF6 release
assay. Pre-60S subunits were isolated from Sbds-
deleted liver cell extracts by sucrose gradient sedi-
mentation, incubated with recombinant release fac-
tors, and pelleted through a 30% (w/v) sucrose
cushion. Immunoblotting revealed the distribution
of eIF6 in the supernatant (‘‘free’’) and pellet (‘‘bound’’).
(B) SBDS and EFL1 are jointly required for GTP-
dependent release of eIF6 from purified pre-60S sub-
units. Indicated combinations of recombinant human
SBDS and EFL1 were incubated with pre-60S subunits
in the presence of GTP. eIF6, Nmd3, and Ebp1 were
visualized by immunoblotting. A minus sign () in-
dicates no added factor. (C) Nucleotide dependence of
eIF6 release by SBDS and EFL1. Recombinant human
SBDS and EFL1 were incubated with pre-60S subunits
in the presence of the indicated guanine nucleotides.
eIF6 and Ebp1 were visualized by immunoblotting.
(D) Ser 235 is not required for GTP-dependent eIF6
release by SBDS and EFL1 in vitro. (Left panel)
Purified RRL 60S subunits (preloaded with eIF61-225)
were incubated with the indicated combinations of
recombinant human SBDS and EFL1 and GTP. (Right
panel) RRL 60S subunits were incubated with SBDS
and EFL1 and the indicated nucleotides. EDTA was
used as a positive control for eIF6 release. eIF6 and
Rpl28 were visualized by immunoblotting. See also
Supplemental Figures S3 and S4 and Supplemental
Tables S1 and S2.
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triphosphate GTP, but not the addition of SBDS, EFL1, or
GTP alone. In the absence of added nucleotide triphos-
phate or the presence of GDP, SBDS and EFL1 failed to
trigger eIF6 removal, and there was only marginal release
in the presence of the nonhydrolysable GTP analog
GDPNP (Fig. 3C). ATP was inactive in the assay (data
not shown). Furthermore, two catalytically inactive EFL1
mutants (T33A and H96A) were defective for eIF6 disso-
ciation (data not shown). Consistent with the hypothesis
that eIF6 removal is specifically triggered by SBDS/EFL1,
there was no detectable dissociation of Ebp1 or Nmd3
(Fig. 3B). Taken together, these data indicate that SBDS
and EFL1 act in concert to directly catalyze eIF6 release
from murine pre-60S particles by a mechanism that
requires both GTP binding and GTP hydrolysis by EFL1.
Furthermore, as EFL1 is highly conserved, we took advan-
tage of a genetic complementation assay in yeast to de-
termine whether GTP hydrolysis is critical for its function
in vivo. Indeed, wild-type but not mutant EFL1 alleles
carrying mutations in key conserved catalytic residues
complemented the growth defect of efl1D yeast cells in
vivo (Supplemental Fig. S4), indicating that GTP binding
and hydrolysis are critical for EFL1 function both in vitro
and in vivo.
Catalysis of eIF6 removal is independent
of Ser 235 phosphorylation
A distinct mechanism of eIF6 release by RACK1 and PKC
has been proposed in mammalian cells involving eIF6
phosphorylation on S235 (Ceci et al. 2003). To assess
whether S235 phosphorylation is required for eIF6 re-
moval in vitro, we prepared salt-washed 60S ribosomal
subunits from rabbit reticulocyte lysate (RRL) and
assayed the ability of SBDS and EFL1 to release prebound
recombinant eIF6 protein truncated after residue N225
(eIF61-225) and therefore excluding S235. Indeed, GTP-
dependent release of eIF61-225, but not ribosomal protein
Rpl28, was promoted when eIF61-225-bound 60S subunits
were incubated with both SBDS and EFL1 (Fig. 3D). As
a positive control, EDTA promoted factor-independent
eIF6 release. Thus, eIF6 that lacks residue S235 can be
specifically released from mature 60S subunits by SBDS
and EFL1 in vitro in the absence of exogenous 40S sub-
units, RACK1, or PKC. We therefore conclude that SBDS
and EFL1 are necessary and sufficient for GTP-dependent
release of eIF6 from 60S subunits in vitro.
To identify specific eIF6 phosphopeptides in mamma-
lian cells, we subjected eIF6-enriched pre-60S particles
isolated from Sbds-deleted mice to analysis by mass
spectrometry. Although we identified eIF6 phosphopep-
tides containing phosphates at residues S174, S175, T165,
and S166 and unambiguously identified multiple tryptic
peptides containing S235, we found no evidence for in
vivo phosphorylation of this residue (Supplemental Table
S2). Thus, phosphorylation of eIF6 on S235 is neither
present in vivo nor required for eIF6 release ex vivo (Fig.
3B,C) or in vitro (Fig. 3D). These data do not support
a requirement for S235 phosphorylation for eIF6 release in
mammalian cells.
High-resolution solution structure of human SBDS and
the impact of disease mutations
We next set out to determine the specific role of the SBDS
protein in the mechanism of eIF6 release. As a prerequi-
site for this, we solved a high-resolution solution NMR
structure of the human SBDS protein (Fig. 4A–E; Supple-
mental Table S3). The secondary structure elements and
overall fold of the human and archaeal SBDS orthologs
(AF0491) (Shammas et al. 2005) are identical, despite only
22% amino acid sequence identity and 42% amino acid
similarity (Supplemental Fig. S3A–D), strongly support-
ing an evolutionarily conserved function. The human
SBDS protein has a three-domain architecture: domain I,
also called the FYSH domain (residues S2–S96); domain II
(residues D97–A170); and domain III (residues H171–
E250). The N (residues S2–V15) and C (residues N238–
E250) termini are unstructured. The N-terminal domain
consists of a twisted five-stranded anti-parallel b sheet
with four a helices positioned on one face of the sheet.
The central domain consists of a three-helical, right-
handed twisted bundle, while the C-terminal domain
has a typical ferredoxin-like fold. Importantly, helix a5
(residues D97–D117) is well defined in our structure, in
contrast with a recent study in which 11 of these residues
(D97–M107) were unassigned and therefore were as-
sumed to be unstructured (de Oliveira et al. 2010).
We directly assessed the impact of SDS-associated
mutations using 15N,1H heteronuclear single-quantum
correlation (HSQC) spectroscopy. Chemical shift pertur-
bation caused by a mutation can be interpreted in terms
of local or global changes in protein conformation, as
15N,1H HSQC spectra provide a fingerprint of the local
environment of all amide resonances. The 29 amino acids
targeted by missense mutations in SDS patients (Supple-
mental Table S4) predominantly map to domains I and II
(Fig. 4A). Overlays of the 15N,1H HSQC spectra for wild-
type SBDS and three representative SDS-associated dis-
ease mutants (C84R, R126T, and K151N) are shown in
Figure 4F, and similar overlays for an additional 25 SBDS
mutants are displayed in Supplemental Figure S2, A–D.
Based on these data, we subdivided SDS-associated mis-
sense mutations into two categories: Class A mutations
affect SBDS protein stability or fold, and class B muta-
tions alter surface epitopes without affecting the SBDS
protein stability or fold (Supplemental Table S5).
Conserved global domain motion of the SBDS proteins
To provide potential insight into its mechanism of action,
we next characterized the dynamic properties of human
and yeast SBDS. Two sets of relaxation experiments were
recorded to distinguish between the overall mobility of
individual domains (longitudinal relaxation rate 15N R1)
and the fast time scale (picosecond) internal mobility of
backbone amide residues ({1H}15N-heteronuclear NOE).
The 15N R1 values show significant variation along the
protein sequence (Fig. 5A,B), indicating that the tumbling
of the SBDS protein is anisotropic. 15N R1 measure-
ments for domain I yielded values significantly lower
than those predicted by hydrodynamic calculations for
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an independently mobile domain, but were higher than
the values anticipated for a completely rigidmodule. These
data indicate that domain I tumbles largely, but not
completely, independently of domains II and III (Figure 5B).
Interestingly, the transition point or hinge between
regions of the SBDSmolecule with differing global motion
is centered within the N terminus of helix a5 (residue
T102), which has a high degree of internal flexibility
(Fig. 5C,D), suggesting that it may convert rapidly be-
tween a fully folded and partially unfolded conforma-
tion. Strikingly, comparison of the backbone relaxation
measurements between humans and yeast reveals that
the dynamic properties of the SBDS proteins are highly
conserved (Fig. 5A,C), although the transition point
(residue Q94) within the yeast protein is shifted eight
residues toward the N terminus. These data indicate that
domain I of SBDS can sample a variety of positions and
potentially propagate conformational change. We consid-
ered the dynamic mobility of SBDS to be reminiscent of
the interdomain motion of bacterial ribosome-recycling
factor (RRF) that is critical for the cooperative interaction
with EF-G in the disassembly of post-termination ribo-
somes (Yoshida et al. 2003; Gao et al. 2007; Savelsbergh
et al. 2009), raising the possibility that the key role of
SBDS might be to tightly couple GTP-dependent confor-
mational change in EFL1 (an EF-G homolog) to the release
of eIF6.
SBDS stimulates 60S-dependent GTP hydrolysis
by EFL1
To address this hypothesis, we first asked whether SBDS
might function as an adaptor that recruits EFL1 to the
pre-60S subunit. However, we found that EFL1 and SBDS
can bind independently to 60S ribosomal subunits in vitro,
with no evidence of significant binding cooperativity in
Figure 4. Solution structure of human SBDS and
impact of SDS-associated mutations. (A) Ribbon
representation of the lowest-energy human SBDS
NMR structure surrounded by the solvent-accessi-
ble surface (radius probe 1.4 A˚), prepared using the
program PyMOL (http://www.pymol.org). Domain I
is colored red, domain II is colored yellow, domain III
is colored green, and loops are colored gray. The
indicated SDS-associated mutations modify surface
epitopes (blue spheres) or protein stability (pink
spheres). (B–D) Overlay of the backbone atoms of
the 20 lowest-energy structures from domain I (A16–
T89) (A), domain II (D97–K164) (B), and domain III
(H171–L237) (C). The 20 conformers were overlaid
using Clusterpose (Diamond 1995). (E) Representa-
tion of the electrostatic surface potential of the
human SBDS protein, calculated by the program
APBS (Baker et al. 2001) and colored using a linear
color ramp from 15 kT (red) to +15 kT (blue). The
SDS-associated mutation K151N is indicated. (F)
Overlays of the 1H,15N HSQC spectra for wild-type
(blue) and three SDS-associated mutants (C84R,
R126T, and K151N) (red). Arrows indicate peaks
visible in the wild-type spectrum but not in the
C84R mutant. See also Supplemental Figures S5 and
S6 and Supplemental Tables S3–S5.
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salt titration experiments (Fig. 6A). We next considered
whether SBDSmight activate GTP hydrolysis by EFL1.We
first confirmed biochemically that recombinant human
EFL1 does indeed have GTPase activity by incubating the
protein with [g-32P]GTP and measuring the release of
inorganic phosphate (Pi). The low intrinsic GTPase activ-
ity of EFL1 was not significantly enhanced by SBDS alone
(Fig. 6B, lanes 1,2). However, as the sarcin–ricin loop (SRL)
is critical for the activation of translational GTPases on
the ribosome (Voorhees et al. 2010), we next askedwhether
the GTPase activity of EFL1 was stimulated by RRL 60S
subunits. Although 60S subunits alone had no significant
intrinsic GTPase activity, they robustly activated GTP
hydrolysis by EFL1 (Fig. 6B, lanes 3,5). As a control, we
tested the ability of 60S subunits to stimulate the GTPase
activity of a catalytically inert EFL1 variant carrying a
missense mutation in a highly conserved catalytic residue
(H96A, corresponding to yeast H106A). In contrast to
wild-type EFL1, we detected no significant 60S-dependent
stimulation of the GTPase activity of the EFL1-H96A
mutant (data not shown). We conclude that the 60S sub-
unit specifically activates the GTPase activity of EFL1.
However, despite 60S-dependent activation of its GTPase
activity, EFL1 alone is insufficient to promote the release
of eIF6 in the absence of SBDS in vitro (Fig. 3B,D) or in vivo
(Fig. 2A–C). We therefore asked whether SBDS signifi-
cantly enhances the 60S-dependent GTPase activity of
EFL1. Indeed, we found that SBDS significantly stimulated
60S-dependent GTP hydrolysis by EFL1 (P < 0.01) (Fig. 6B,
lanes 5,7). In contrast, Pi release by the catalytically inert
EFL1 mutant H96A was not enhanced on incubation
with 60S subunits and SBDS (Fig. 6B, lane 6), indicating
that SBDS specifically stimulates Pi release from EFL1
and not from another contaminating ribosomal GTPase.
In an experiment in which 60S-dependent GTP hydroly-
sis by EFL1 was measured as a function of GTP concen-
tration, SBDS induced a twofold increase in Vmax for the
reaction (Fig. 6B, inset). We conclude that SBDS signifi-
cantly stimulates the 60S-dependent GTPase activity of
EFL1 under multiple turnover conditions.
SBDS tightly couples GTP hydrolysis by EFL1
on the ribosome to eIF6 release
We postulated that the critical role of SBDS might be to
tightly couple the activation of EFL1 GTP hydrolysis on
the ribosome with eIF6 release, and that specific SDS-
associated missense mutants might abrogate this activ-
ity. To test this hypothesis, we examined the function of
two class B missense SBDS mutants (R126T and K151N)
in three independent assays: pre-60S subunit binding, stim-
ulation of EFL1 60S-dependent GTPase activity, and ability
to drive eIF6 release from pre-60S ribosomal subunits.
The SbdsR126T disease-associated allele is a functional
hypomorph in vivo and the R126T mutant protein is ex-
pressed at wild-type levels in fibroblasts homozygous for
Figure 5. Conserved interdomain motion of the SBDS protein. (A) Quasi-independent mobility of domain I relative to domains II and
III. The experimentally determined longitudinal relaxation rate 15N R1 (sec
1) for human (blue circles) and yeast (red triangles) SBDS is
plotted against human SBDS residue number. Black circles represent 15N R1 (sec
1) values calculated for a simulated fully rigid SBDS
model, and gray triangles represent 15N R1 (sec
1) values calculated for a simulated model in which the motion of domain I is
completely independent of domains II and III. (B) Schematic representation of the quasi-independent mobility of domain I (red) relative
to domains II and III (blue). Arrow indicates the hinge region at the N terminus of helix a5. (C) {1H}15N-heteronuclear NOE values for
human (blue circles) and yeast (red triangles) SBDS proteins plotted against human SBDS residue number. Residues for which no data
are shown correspond to prolines or overlapped cross-peaks. (D) {1H}15N-heteronuclear NOE values mapped onto a ribbon
representation of the human SBDS structure. Residues are colored from most (red) to least (blue) flexible.
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the SbdsR126T allele (Ball et al. 2009), indicating that it is
functionally defective. Residue R126 lies on the surface of
the a5–a6 loop at the interface between domains II and III
(Fig. 4A). The 15N,1H HSQC spectrum of the R126T
mutant displayed only local chemical shift perturbation
of residues within loops a5–a6 and a7–b6 (Fig. 4F),
indicating that it is has the same fold as wild-type SBDS.
Although the R126T mutant bound efficiently to pre-60S
subunits (Supplemental Fig. S7), it did not significantly
enhance the 60S-dependent GTPase activity of EFL1
compared with wild-type SBDS (Fig. 6B, lanes 5,7,8).
Furthermore, R126T was strongly defective compared
with wild-type SBDS in triggering eIF6 release in concert
with EFL1 and GTP (Fig. 6C). These data are consistent
with the hypothesis that the primary defect in SDS is
impaired release of eIF6 from pre-60S ribosomes.
Residue K151 is conserved between yeast and human
SBDS and localizes to a basic patch on helix a7 on the
surface of domain II (Fig. 4A; Supplemental Fig. S5). The
15N,1H HSQC spectrum of the K151N mutant displayed
no significant chemical shift perturbation compared with
wild-type SBDS (Fig. 4F). Although K151N bound effi-
ciently to pre-60S ribosomal subunits (Supplemental Fig.
S7), it was strongly defective compared with wild-type
SBDS in triggering eIF6 dissociation with EFL1 and GTP
(Fig. 6C). However, in contrast to R126T, the K151N
mutant significantly stimulated the 60S-dependent
GTPase activity of EFL1 (P < 0.01), and the degree of
stimulation was not significantly different compared
with wild type (Fig. 6B, lane 9). Thus, the K151N mutant
is defective in eIF6 release despite significantly stimulat-
ing 60S-dependent GTP hydrolysis by EFL1.
Finally, we took advantage of the conservation of residue
K151 in yeast SDO1 to examine the effect of the K151N
mutation on SDO1 function in vivo by genetic comple-
mentation. As the sole source of SDO1, the sdo1-K151N
allele failed to complement the fitness defect of sdo1D
yeast cells despite appropriate expression (data not shown),
indicating that residue K151 is critical for SDO1 func-
tion in vivo. Thus, we conclude that, although SBDS can
significantly stimulate the 60S-dependent GTPase activity
of EFL1 in multiple turnover conditions, its essential role
is to tightly couple the activation of EFL1 GTP hydrolysis
on the ribosome to eIF6 release.
Discussion
Our study describes the establishment of an ex vivo
system that reconstitutes a late cytoplasmic step in the
maturation of pre-60S ribosomal subunits. This system
allows us to conclude that (1) human SBDS is an essential
cofactor for the EFL1 GTPase, and together they co-
operate to directly catalyze the release of eIF6 from
mammalian pre-60S ribosomal subunits; (2) the mecha-
nism of eIF6 release requires GTP binding and hydrolysis
by EFL1, but is independent of eIF6 phosphorylation on
Ser 235; (3) SBDS stimulates 60S-dependent GTP hydro-
lysis by EFL1, but its essential role is to tightly couple
the activation of EFL1 GTP hydrolysis on the ribosome
to eIF6 release; and (4) a conserved lysine (K151) that is
mutated in SDS and maps to the central three-helical
bundle of the SBDS protein is required for cooperativity
with EFL1. Taken together with the comprehensive
high-resolution NMR structural and dynamic analysis
of both human and yeast SBDS proteins reported here,
Figure 6. SBDS tightly couples activation of EFL1 GTP hydro-
lysis to eIF6 release. (A) SBDS and EFL1 bind independently to
60S subunits. SBDS and EFL1 were bound to RRL 60S subunits
over the indicated range of KCl concentrations and pelleted
through 30% (w/v) sucrose cushions. Bound SBDS, EFL1, and
Rpl28 were visualized by immunoblotting. (B) SBDS stimulates
60S-dependent GTP hydrolysis by EFL1. 60S-dependent GTPase
activity of human wild-type EFL1 or a catalytically inactive
mutant (H96A) was measured in the presence of wild-type or
variant (R126T and K151N) SBDS. The experiment was repeated
three times and the average values with SD are presented. (Inset)
Dose response curve for 60S-dependent EFL1 catalytic activity
as a function of GTP concentration in the presence (black line)
or absence (red line) of human SBDS. Measurements were
performed in duplicate. (C) SDS-associated SBDS variants are
defective in eIF6 release. Pre-60S subunits were incubated with
GTP, EFL1, and either wild-type or variant (R126T or K151N)
SBDS proteins. Following sucrose pelleting, ‘‘bound’’ and ‘‘free’’
fractions were immunoblotted to visualize eIF6 and Ebp1. See
also Supplemental Figure S7.
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our findings provide key insights into the molecular
mechanism of a fundamental and pivotal step that is
required for the translational activation of ribosomes
in all eukaryotes (summarized in the model shown in
Fig. 7). This study is the first to link the etiology of the
liver pathology associated with the clinical syndrome of
SDS to defective 60S subunit maturation, and provides
compelling evidence that SDS is a ribosomopathy that is
caused by uncoupling GTP hydrolysis by EFL1 on the
ribosome from eIF6 release.
Molecular mechanism of eIF6 release
Based on our genetic, structural, and biochemical data,
we propose an evolutionarily conserved model in which
SBDS tightly couples the energy of EFL1 GTP hydrolysis
and Pi release to eIF6 dissociation through a conforma-
tional coupling mechanism (Fig. 7), mimicking aspects
of the cooperative interaction between RRF and EF-G in
ribosome disassembly (Savelsbergh et al. 2009). As the
cellular concentration of GTP is higher than that of
GDP, EFL1 likely associates in its GTP-bound form with
the GTPase-associated center of the pre-60S subunit
(Graindorge et al. 2005; Voorhees et al. 2010), probably
in close physical proximity to SBDS (C Wong and N
Basse, unpubl.), with eIF6 localized in the vicinity of the
dynamic intersubunit bridge B6 (Gartmann et al. 2010).
As GTP binding and hydrolysis precede the dissociation
of eIF6 from the pre-60S subunit (Fig. 3A–D), it is likely
that EFL1 undergoes GTP-dependent conformational
change on the ribosome, analogous to its structural homo-
log, EF-G. The flexible attachment of domain I of SBDS to
domains II and III (Fig. 5A–D) raises the possibility that
interdomain motion may be important for its function in
eIF6 dissociation. We therefore suggest that, following
GTP hydrolysis and Pi release (Fig. 6B), conformational
change in EFL1 induces a domain rotation in SBDS that in
turn drives a structural rearrangement of the ribosome,
displacing the B6 bridge, destabilizing the interaction of
eIF6 with the pre-60S subunit, and triggering eIF6 dissoci-
ation. However, further experiments will be required to
fully elucidate the structural basis for the cooperative
interaction between SBDS and EFL1. As SBDS and EFL1
are not observed on mammalian polysomes, they likely
dissociate following eIF6 release, but the precise timing for
this event is unknown. Furthermore, SBDS and EFL1 can
directly evict eIF6 from mature 60S subunits in vitro,
suggesting that, at least in mammals, this eIF6 recycling
mechanism may function to promote translation by en-
hancing the pool of available free 60S subunits.
In yeast, the release of eIF6 appears to be upstream and
a prerequisite for the removal of Nmd3 from pre-60S
particles by the GTPase Lsg1 (Lo et al. 2010). Consistent
with these data, we observed accumulation of cytoplas-
mic pre-60S particles carrying Lsg1, Nmd3, and eIF6 in
the absence of Sbds (Fig. 2C). In the presence of Lsg1, it
was therefore unexpected that Nmd3 persisted on the
pre-60S particles following release of eIF6, suggesting that
an additional factor or modification of Lsg1 may be
required to drive Nmd3 release. Our ability to reconsti-
tute the final steps of 60S maturation ex vivo provides an
important platform to further dissect the mechanism of
Nmd3 release.
SDS as a ribosomopathy
Our findings provide compelling evidence that autosomal
recessive SDS is a ribosomopathy in which the primary
defect is the uncoupling of GTP hydrolysis by EFL1 on the
ribosome from eIF6 release during late cytoplasmic
maturation of pre-60S ribosomal subunits. Autosomal
dominant Diamond-Blackfan anemia is associated with
mutations in an increasing number of genes encoding
ribosomal proteins (RPs) of the small and large ribosomal
subunits (Boria et al. 2010), and the 5q syndrome, an
Figure 7. Model of eIF6 release by SBDS and EFL1. (1) SBDS
stimulates 60S-dependent GTP hydrolysis by EFL1, generating
EFL1.GDP.Pi. (2) Following release of inorganic Pi, EFL1 adopts
its GDP-bound conformation and domain I of SBDS is rotated
relative to domains II and III, directly or indirectly disrupting
the intersubunit bridge B6. (3) Binding of eIF6 is destabilized,
release of eIF6 is triggered, and EFL1.GDP and SBDS dissociate
from the ribosome. Release of eIF6 allows the formation of
actively translating 80S ribosomes. The putative conformations
of EFL1 are not indicated.
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acquired subtype of MDS, is linked to haploinsufficiency
of the RPS14 gene (Ebert et al. 2008; Barlow et al. 2010a).
Thus, the primary defect underlying SDS is distinct from
the other ribosomopathies associated with hematologi-
cal disease. We suggest that the diverse alternate func-
tions proposed for SBDS in mammalian cells (Wessels
et al. 2006; Austin et al. 2008; Rujkijyanont et al. 2008; Ball
et al. 2009; Leung et al. 2010) are downstream secondary
consequences of the primary defect in 60S ribosomal sub-
unit maturation.
How do we explain the SDS phenotype? It seems likely
to reflect, at least in part, the sensitivities of specific cell
types to cellular stress responses during development that
result from defective ribosome biogenesis. Indeed, recent
in vivo data have established the RP–Mdm2 interaction
as a p53 stress signaling pathway that is activated by aber-
rant ribosome biogenesis and is essential to protect against
oncogenic c-MYC-induced tumorigenesis (Macias et al.
2010). Furthermore, the p53 dependence of the pathologies
associated with defective ribosome biogenesis is supported
by genetic data in a number of animalmodels (Barlow et al.
2010b).
The dramatic disruption of nucleolar architecture in
Sbds-deleted livers is consistent with the hypothesis that
nucleolar stress may contribute to the observed hepato-
cyte defects following complete deletion of Sbds. How-
ever, as SDS is a consequence of partial, not complete,
loss of SBDS function, further work will be required to
clarify the importance of nucleolar stress responses to the
clinical SDS phenotype. Nevertheless, as abnormal liver
function tests and hepatomegaly are recognized features
of SDS at an early age (Toiviainen-Salo et al. 2009), this
study directly links the etiology of a pathological abnor-
mality associated with the clinical syndrome of SDS to
defective 60S subunitmaturation and a ribosomal subunit-
joining defect.
Our findings demonstrate the feasibility and power of
biochemically recapitulating late maturation of mamma-
lian ribosomal subunits ex vivo to elucidate the underly-
ing molecular mechanisms. Finally, this study strongly
supports the hypothesis that small molecules that mimic
the effects of TIF6 suppressor mutations in yeast may
have utility in the treatment of SDS and possibly other
forms of bone marrow failure.
Materials and methods
Protein expression and purification
Recombinant human eIF6 (NP_852133) and SBDS (NP_057122)
were expressed and purified from Escherichia coli, and human
EFL1 (NP_078856) was expressed and purified from S. cerevisiae.
Recombinant proteins were purified by Ni-NTA affinity and gel
filtration chromatography. See the Supplemental Material for
detailed protocols.
NMR spectroscopy
NMR spectra were assigned and the solution structure was
determined using standard techniques (Wu¨thrich 1986; Bax
1994).
Mouse gene targeting
The mouse genomic Sbds locus was PCR-amplified from mouse
129 DNA. The targeting vector pMCTV1 was generated such
that exposure to Cre recombinase results in deletion of exon 2
and the selection cassette. All animal experiments were under-
taken with the approval of the UK Home Office.
Sucrose density gradients
Frozen liver (typically 30 mg) was homogenized with a pestle in
detergent lysis buffer A (10 mM Tris-HCl at pH 7.4, 10 mM
NaCl, 1.5 mM MgCl2, 0.5% [v/v] Triton X-100, 0.5% [w/v]
deoxycholate, 1% [v/v] Tween 20, 100 mg/mL cycloheximide)
with complete EDTA-free protease inhibitors (Roche) and 0.5
U/mL RNase inhibitor (Promega) and incubated for 10 min on
ice. Lysates were cleared in a microfuge. Equal amounts (typi-
cally 10–20 A254 U) were applied to a 10%–50% (w/v) sucrose
gradient in 30 mL of buffer B (10 mM Tris-HCl at pH 7.4, 75 mM
KCl, 1.5 mM MgCl2) and centrifuged (Beckmann SW32 rotor) at
32,000 rpm for 2 h and 46 min at 4°C. For ribosome profiles, liver
lysates were prepared in buffer A (without MgCl2 or cyclohex-
imide) in the presence of 5 mM EDTA;MgCl2 was removed from
the sucrose gradient buffer B.
Samples were unloaded using a Brandel gradient fractionator,
the polysome profiles were detected using a UV monitor (UV-1,
Pharmacia) at A254, and 1-mL fractions were collected. The
electronic outputs of the UV-1 monitor and fraction collector
were fed into a Labjack U3-LV data acquisition device with a
LJTick-InAmp preamplifier. Proteins were precipitated from su-
crose gradient fractions with 10% (v/v) trichloroacetic acid (TCA),
separated on SDS-PAGE gels and transferred to PVDFmembranes
for immunoblotting.
Preparation of liver extracts and immunoblotting
Whole-liver extracts were prepared by homogenizing 10 mg of
liver in RIPA buffer C (20 mM HEPES at pH 7.4, 20 mM
b-glycerophosphate, 10 mMNaF, 0.5 mMEDTA, 0.5 mMEGTA,
0.2 M NaCl, 1% [v/v] Nonidet P-40, 0.5% [w/v] sodium deoxy-
cholate, 0.1% [w/v] SDS) with complete EDTA-free protease
inhibitors (Roche) using a pellet pestle (Sigma) and leaving for
10 min on ice with occasional vortexing. Samples were cleared
in a microfuge and normalized for protein concentration using
a BCA protein assay kit (Pierce). Samples were fractionated using
NE-PER nuclear and cytoplasmic extraction reagents (Pierce)
according to the manufacturer’s instructions. All fractions were
normalized against the protein concentration of the cytoplasmic
fractions.
eIF6 release assay
The reaction mixture (100 mL) contained 50 mL of sucrose
gradient-purified 60S subunits (;0.5–1 pmol); 5 pmol of SBDS;
5 pmol of EFL1; 100 mM purified GTP, GDP, or GDPNP (Sigma)
in buffer B with complete EDTA-free protease inhibitors (Roche);
and 0.5 U/mL RNasin (Promega). GDP and GTP were purified as
in Wilden et al. (2006).
Alternatively, 5 pmol of 60S subunits was purified from RRL
(Pisarev et al. 2007) and incubated with an excess of recombinant
eIF61-225 for 20 min on ice, and free eIF6 was removed using
a 100-kDa Microcon centrifugal filter unit (Sigma). The eIF6-
loaded RRLwas then used as a substrate in the eIF6 release assay.
Reaction mixtures were incubated for 10 min at 37°C, layered
onto a 150-mL 30% (w/v) sucrose cushion in buffer B, and
centrifuged (Beckmann TLA120.1 rotor) at 120,000 rpm for 30
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min at 4°C. Two-hundred microliters of supernatant (‘‘free’’)
was removed, and the remaining 50 mL was resuspended
(‘‘bound’’) in 150 mL of buffer B. Samples were TCA-precipitated
for immunoblotting.
RRL 60S-binding assay
The reaction mixture (100 mL) contained 5 pmol of 60S subunits
purified from RRL (Pisarev et al. 2007) with 25 pmol each of
SBDS and EFL1 in buffer B. Additional KCl was added where
specified. Samples were subsequently processed as above for eIF6
release.
60S-dependent GTP hydrolysis by EFL1
The reaction mixture (50 mL) contained 5 nmol of [g-32P]GTP (6
Ci/mmol; Perkin-Elmer), 5 pmol of RRL 60S subunits, 6.3 pmol of
SBDS, and 40 pmol of EFL1 in buffer D (50 mM Tris at pH 7.4, 2
mM MgCl2, 150 mM NaCl, 2 mM DTT). The reaction mixture
was incubated for 30 min at 37°C. An aliquot (40 mL) of the
reaction mix was added to 360 mL of chilled charcoal slurry
(5% [v/v] Norit in 50 mM NaH2PO4, at pH 3.0) and centrifuged
at 13,000 rpm for 10 min. The amount of radioactivity in 100 mL
of supernatant was quantified by liquid scintillation counting.
Yeast strains and plasmids
S. cerevisiae strains used in this study are listed in Supplemental
Table S6 and primers are listed in Supplemental Table S7.
Deletion strains were generated by homologous recombination
using appropriate PCR products to transform strain Y5538. The
coding sequence for wild-type EFL1 was PCR-amplified from
yeast genomic DNA and cloned into pYCT/C2 to generate plasmid
pEFL1. Plasmids pEFL1-T33A, pEFL1-D102A, pEFL1-H106A, and
pEFL1-H106I, pEFL1-D159A, pEFL1-W240E were generated by
QuickChange site-directed mutagenesis (Stratagene).
Suppressor clone isolation
Suppressor clone isolation was performed as described (Menne
et al. 2007).
Synthetic genetic array analysis and random
sporulation assays
SGA and random sporulation analysis was performed as
described (Tong and Boone 2006; Baryshnikova et al. 2010;
Costanzo et al. 2010). MATa efl1DTNatMX4 TIF6-R61G and
MATa sdo1DTNatMX4 TIF6-R61G query strains harboring SGA
markers and haploid-specific reporters were crossed to an array
containing the set of ;5000 viable deletion mutant strains.
Nourseothricin was obtained from Werner BioAgents.
Peptide separation, mass spectrometry, and database analysis
For peptide separation, mass spectrometry, and database analysis
used in this study, see the Supplemental Material.
Antibodies
For antibodies used in this study, see the Supplemental Material.
Statistical analysis
Student’s t-test was used to determine significant differences. P <
0.01 was considered significant.
Accession numbers
Coordinates for the human SBDS structure have been deposited
in the Protein Data Bank (ID 2L9N), and the 1H, 15N, and 13C
chemical shifts have been deposited in the BioMagResBank
database (accession code 17479).
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